Product Information |
|
Registration Number |
DR-XY47322
|
Generic Name |
Olopatadine (as hydrochloride) + Mometasone furoate
(as monohydrate)
|
Brand Name |
Ryaltris
|
Dosage Strength |
665 mcg/25 mcg per actuation
|
Dosage Form |
Nasal Suspension
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
-
|
Packaging |
White opaque round HDPE bottle containing 240 actuations with a crimped nasal spray pump fitted into a white actuator and purple HDPE cap (Box of 1's) White opaque round HDPE bottle containing 120 actuations with a crimped nasal spray pump fitted into a white actuator and purple HDPE cap (Box of 1's) White opaque round HDPE bottle containing 56 actuations with a crimped nasal spray pump fitted into a white actuator and purple HDPE cap (Box of 1's) [Physician's Sample)
|
Manufacturer |
Glenmark Pharmaceuticals Ltd.
|
Country of Origin |
India
|
Trader |
|
Importer |
Glenmark Philippines, Inc.
|
Distributor |
Glenmark Philippines, Inc.
|
Application Type |
-
|
Issuance Date |
13 July 2021
|
Expiry Date |
13 July 2026
|